Baillie Gifford acquired 10.1M Sana Biotechnology shares worth $30M. That's 0.02% of their equity portfolio (168th largest holding). The investor owns 4.13% of the outstanding Sana Biotechnology stock. The first Sana Biotechnology trade was made in Q1 2021. Since then Baillie Gifford bought shares four more times and sold shares on thirteen occasions. The investor's estimated purchase price is $303M, resulting in a loss of 90%.
Baillie Gifford Bolsters Stake in Sana Biotechnology Inc
Baillie Gifford Reduces Stake in Sana Biotechnology Inc